Francois Nader's Net Worth
$24.1 Million
Who is Francois Nader?
Francois Nader has an estimated net worth of $24.1 Million. This is based on reported shares across multiple companies, which include Moderna, Inc., Talaris Therapeutics, Inc., Prevail Therapeutics Inc., TREVENA INC, Baxalta Inc, NPS PHARMACEUTICALS INC, ACCELERON PHARMA INC, ALEXION PHARMACEUTICALS INC, and NOVEN PHARMACEUTICALS INC.
SEC CIK
Francois Nader's CIK is 0001365343
Past Insider Trading and Trends
2013 was Francois Nader's most active year for acquiring shares with 39 total transactions. Francois Nader's most active month to acquire stocks was the month of January. 2013 was Francois Nader's most active year for disposing of shares, totalling 44 transactions. Francois Nader's most active month to dispose stocks was the month of January. 2019 saw Francois Nader paying a total of $1,087,081.83 for 69,085 shares, this is the most they've acquired in one year. In 2015 Francois Nader cashed out on 1,595,748 shares for a total of $13,877,663.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $72.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| +2,831.29% | 19.9K |
$77.49 | $921.40 | 20.61K |
Scheduled
|
May 10
| ||
Form 4
|
∞
| 703 |
—
|
—
| 703 |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Talaris Therapeutics, Inc. (TRML) Snapshot price: $16.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4/A
| +35.00% | 138.5K |
$3.61 | $500,020.00 | 534.19K |
Jul 19 - Jul 25
| |||
Form 4
| +41.20% | 138.5K |
$3.61 | $500,020.00 | 474.67K |
Jul 19 - Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| -15.04% | -59.52K |
—
|
—
| 336.17K |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prevail Therapeutics Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -23.75K |
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
∞
| 23.75K |
—
|
—
| 23.75K |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TREVENA INC (TRVN) Snapshot price: $3.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Baxalta Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.66K |
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +142.54% | 4.5K |
—
|
—
| 7.66K |
May 10
| |||
Form 4
| -50.00% | -3.14K |
—
|
—
| 3.14K |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||